Side-by-side comparison of AI visibility scores, market position, and capabilities
Gurugram India YC S22 dermatology telemedicine at $9.9M revenue 2024 with 1.5M customers; $3.1M total ($2.6M Tribe/Goodwater/Sequoia seed Sep 2023) competing with Practo for India digital dermatology care.
Clinikally is a Gurugram, India-based dermatology telemedicine and online pharmacy platform — backed by Y Combinator (S22) with $3.1 million in total funding including a $2.6 million seed in September 2023 led by Tribe Capital with Goodwater Capital, Sequoia Capital, and Rebel Fund — providing 1.5 million customers with integrated dermatological consultations, AI-assisted skin analysis, and prescription delivery for skin and hair conditions through a digital-first model that democratizes access to dermatology care across India. Founded in 2022 by Arjun Soin, Clinikally achieved $9.9 million in revenue in 2024 with a 76-person team, addressing the significant dermatology care access gap in a country where there are fewer than 10,000 dermatologists for 1.4 billion people.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.